Together, the results of the experiments in Figure 4 and Figure 5 provide evidence that the use of small molecule inhibitors of UCH-L1 DUB activity might be beneficial for treatment of selected metastatic carcinomas. This evidence concerns the gene UCHL1 and metastatic carcinoma.